Latest news articles

Added 2 months ago Drug news

Shionogi reports positive results from cefiderocol phase III study in adults with pneumonia caused by gram-negative pathogens.

Shionogi & Co., Ltd. announced results from APEKS-NP, an international, double-blind, randomized Phase III clinical trial evaluating the efficacy and...

Added 3 months ago Drug news

PREPARE Phase III trial of ResVax shows efficacy in respiratory syncytial virus

Novavax announced the presentation of new data from the company’s Prepare trial, a global Phase III clinical trial of ResVax...

Added 4 months ago Drug news

FibroGen announces first patient dosed in ZEPHYRUS, a phase III clinical trial of pamrevlumab for idiopathic pulmonary fibrosis.

FibroGen, Inc. announced dosing of the first patient in the ZEPHYRUS Phase III clinical study of pamrevlumab in patients with...

Search all news articles for Other lower respiratory disease

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more

Load more


ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.

These guidelines incorporate the recent advances in chronic cough pathophysiology, diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella term that explains the exquisite sensitivity of patients to external stimuli

Added 2 months ago

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Background: This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society...

Added 2 months ago

Search all guidelines for Other lower respiratory disease

Journal articles

Comparison of disease progression subgroups in idiopathic pulmonary fibrosis.

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial pneumonia with an unpredictable course. The aims of this study were to retrospectively re-evaluate a cohort of patients with IPF according to the 2011...

Added 7 days ago

Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden.

Background: Idiopathic pulmonary fibrosis (IPF) is a disease with poor prognosis mainly affecting males. Differences in clinical presentation between genders may be important both for the diagnostic work-up and for follow-up.

Added 7 days ago

Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-analysis.

Objective: This meta-analysis aims to present a collective view on the relationship between viral infection and IPF.

Added 7 days ago

Search all journal articles for Other lower respiratory disease

Clinical trials

Inhaled NAC in Treatment of IPF

This study plans to learn more about the safety and tolerability of inhaled N-Acetylcysteine (NAC) in patients with pulmonary fibrosis. The study will also create a bank of data, blood, and sputum from IPF patients for future research.

Added 1 month ago

Evaluation of Efficacy and Safety of Pamrevlumab in Patients With Idiopathic Pulmonary Fibrosis

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in subjects with Idiopathic Pulmonary Fibrosis

Added 5 months ago

A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of TD139.

Added 1 month ago

Search all clinical trials for Other lower respiratory disease


Management of acute cough in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Other lower respiratory disease